scispace - formally typeset
Search or ask a question
Author

Chun-Su Yuan

Bio: Chun-Su Yuan is an academic researcher from University of Chicago. The author has contributed to research in topics: Ginseng & American ginseng. The author has an hindex of 72, co-authored 397 publications receiving 21089 citations. Previous affiliations of Chun-Su Yuan include South University & University of Illinois at Chicago.


Papers
More filters
Journal ArticleDOI
TL;DR: This commentary aims to review selected effects of ginseng and ginsenosides and describe their possible modes of action, structural and functional relationship to steroids, and potential targets of action.

1,816 citations

Journal ArticleDOI
TL;DR: The ASRA consensus statements represent the collective experience of recognized experts in the field of neuraxial anesthesia and anticoagulation and are based on case reports, clinical series, pharmacology, hematology, and risk factors for surgical bleeding.

1,319 citations

Journal ArticleDOI
TL;DR: Neuraxial anesthesia and analgesia provide several advantages over systemic opioids, including superior analgesia, reduced blood loss and need for transfusion, decreased incidence of graft occlusion, and improved joint mobility following major knee surgery.

926 citations

Journal ArticleDOI
11 Jul 2001-JAMA
TL;DR: During the preoperative evaluation, physicians should explicitly elicit and document a history of herbal medication use to prevent, recognize, and treat potentially serious problems associated with their use and discontinuation.
Abstract: ContextWidespread use of herbal medications among the presurgical population may have a negative impact on perioperative patient care.ObjectivesTo review the literature on commonly used herbal medications in the context of the perioperative period and provide rational strategies for managing their preoperative use.Data SourcesThe MEDLINE and Cochrane Collaboration databases were searched for articles published between January 1966 and December 2000 using the search terms herbal medicine, phytotherapy, and alternative medicine and the names of the 16 most commonly used herbal medications. Additional data sources were obtained from manual searches of recent journal articles and textbooks.Study SelectionWe selected studies, case reports, and reviews addressing the safety and pharmacology of 8 commonly used herbal medications for which safety information pertinent to the perioperative period was available.Data ExtractionWe extracted safety, pharmacodynamic, and pharmacokinetic information from the selected literature and reached consensus about any discrepancies.Data SynthesisEchinacea, ephedra, garlic, ginkgo, ginseng, kava, St John's wort, and valerian are commonly used herbal medications that may pose a concern during the perioperative period. Complications can arise from these herbs' direct and pharmacodynamic or pharmacokinetic effects. Direct effects include bleeding from garlic, ginkgo, and ginseng; cardiovascular instability from ephedra; and hypoglycemia from ginseng. Pharmacodynamic herb-drug interactions include potentiation of the sedative effect of anesthetics by kava and valerian. Pharmacokinetic herb-drug interactions include increased metabolism of many drugs used in the perioperative period by St John's wort.ConclusionsDuring the preoperative evaluation, physicians should explicitly elicit and document a history of herbal medication use. Physicians should be familiar with the potential perioperative effects of the commonly used herbal medications to prevent, recognize, and treat potentially serious problems associated with their use and discontinuation.

822 citations

Journal ArticleDOI
01 Jun 2002-Diabetes
TL;DR: Antihyperglycemic and anti-obese effects of Panax ginseng berry extract and its major constituent, ginsenoside Re, in obese diabetic C57BL/6J ob/ ob mice and their lean littermates were evaluated, suggesting that other constituents in the extract have distinct pharmacological mechanisms on energy metabolism.
Abstract: We evaluated antihyperglycemic and anti-obese effects of Panax ginseng berry extract and its major constituent, ginsenoside Re, in obese diabetic C57BL/6J ob / ob mice and their lean littermates. Animals received daily intraperitoneal injections of Panax ginseng berry extract for 12 days. On day 12, 150 mg/kg extract–treated ob / ob mice became normoglycemic (137 ± 6.7 mg/dl) and had significantly improved glucose tolerance. The overall glucose excursion during the 2-h intraperitoneal glucose tolerance test decreased by 46% ( P ob / ob mice. The improvement in blood glucose levels in the extract-treated ob / ob mice was associated with a significant reduction in serum insulin levels in fed and fasting mice. A hyperinsulinemic-euglycemic clamp study revealed a more than twofold increase in the rate of insulin-stimulated glucose disposal in treated ob / ob mice (112 ± 19.1 vs. 52 ± 11.8 μmol · kg −1 · min −1 for the vehicle group, P ob / ob mice lost a significant amount of weight (from 51.7 ± 1.9 g on day 0 to 45.7 ± 1.2 on day 12, P ob / ob mice), associated with a significant reduction in food intake ( P P P ob / ob mice. Additional studies demonstrated that ginsenoside Re plays a significant role in antihyperglycemic action. This antidiabetic effect of ginsenoside Re was not associated with body weight changes, suggesting that other constituents in the extract have distinct pharmacological mechanisms on energy metabolism.

568 citations


Cited by
More filters
Journal ArticleDOI
01 Jun 2008-Chest
TL;DR: This article discusses the prevention of venous thromboembolism (VTE) and is part of the Antithrombotic and Thrombolytic Therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

3,944 citations

Journal ArticleDOI
01 Sep 2004-Chest
TL;DR: This article discusses the prevention of venous thromboembolism (VTE) and is part of the Seventh American College of Chest Physicians Conference on Antithrombotic and Thrombolytic Therapy: Evidence-Based Guidelines.

3,064 citations

01 May 2005

2,648 citations